Research ArticleCardiology
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn and Wolfgang A. Weber
Journal of Nuclear Medicine December 2019, 60 (12) 1743-1749; DOI: https://doi.org/10.2967/jnumed.119.226993
Zohreh Varasteh
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
Sarajo Mohanta
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
3German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and
Stephanie Robu
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
Miriam Braeuer
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
Yuanfang Li
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
Negar Omidvari
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
Geoffrey Topping
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
Ting Sun
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
Stephan G. Nekolla
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
Antonia Richter
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
Christian Weber
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
3German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and
Andreas Habenicht
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
Uwe A. Haberkorn
4Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
Wolfgang A. Weber
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn, Wolfgang A. Weber
Journal of Nuclear Medicine Dec 2019, 60 (12) 1743-1749; DOI: 10.2967/jnumed.119.226993
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn, Wolfgang A. Weber
Journal of Nuclear Medicine Dec 2019, 60 (12) 1743-1749; DOI: 10.2967/jnumed.119.226993
Jump to section
Related Articles
Cited By...
- Toward Quantitative Multisite Preclinical Imaging Studies in Acute Myocardial Infarction: Evaluation of the Immune-Fibrosis Axis
- Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
- Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided Therapy
- [68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis
- PET imaging of fibroblast activation protein alpha (FAP) detects incipient cardiotoxicity due to anthracycline chemotherapy
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- [68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
- Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 2: Inflammation, Fibrosis, Thrombosis, Calcification, and Amyloidosis Imaging
- Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
- PET/MRI, Part 4: Clinical Applications
- Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
- The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease
- Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
- The Latest Developments in Imaging of Fibroblast Activation Protein
- FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart
- The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year
- The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
- CARTing Away Cardiac Fibrosis
- FAP: The Next Billion Dollar Nuclear Theranostics Target?